Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
£2,760,000
value
GBP
30 Apr 2025
awarded
6
suppliers named
Who
| Buyer | East Midlands Pharmacy Collaborative — not a council we hold |
| Supplier | Alcura Healthcare Ltd. |
| Supplier | B. Braun Medical Limited |
| Supplier | HealthNet Homecare (UK) Limited |
| Supplier | LloydsPharmacy Clinical Homecare |
| Supplier | Pharmaxo Pharmacy Services Ltd |
| Supplier | Sciensus Pharma Services Limited |
What
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
Dates and source
| Runs | 1 May 2025 to 30 Apr 2027 |
| OCID | ocds-b5fd17-e8653637-3725-450a-adef-4614a52dc955 |
| Notice | Read it on Contracts Finder |
Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.